It is difficult to predict which stock in the stock market will take its investors from the floor to the zenith in one fell swoop. A similar miracle has been done by the stock of a biotech company, which jumped by 177% in just one day of trading and this stock became a money printing machine (Multibagger Stock) for those who invested in it. This sharp rise in this stock has come after a news.
American stocks made rich
The share we are talking about is not listed in the Indian Stock Market, but is listed in the US Stock Market. The shares of American biotechnology company Moderna have done this miracle and in a single day it became profitable for investors. multibagger stock Has become. During trading in the American stock market last trading day, it opened at $116.02 as compared to its previous closing of $62.51.
There was no break on the initial momentum of Moderna Share, but as the trading progressed, it started running at the speed of rocket and was seen trading at 176.66 with a gain of more than 177%, which is also its new all-time high level. This momentum continued till closing in the American stock market and finally Moderna shares closed at $174.38 with a jump of 173%.
Money increased six times in 1 year
Moderna Share has been continuously showering money on its investors for the last one year. This can be gauged from the fact that during this period this pharma stock has increased by 548.49% and its price has increased by $147.49. That means the amount of investors investing money in this stock has increased six times.
Not only in one year, but in the last six months itself, this Moderna stock has given strong multibagger returns to investors, which is 250%. This American stock has jumped 194% in the last one month.
Connection to Covid-19, this is the reason for the rise
America Moderna Inc, which is creating chaos in the stock market, also has a connection with Covid. Actually, this American biotechnology company is famous for the Covid-19 vaccine. Talking about the reasons behind the 177% jump in its shares in a single day, there is a news about the company. In fact, its cancer vaccine being developed by Moderna in collaboration with Merck has been successful in a major final stage trial.
Giving information about this success, both the companies have said that their experimental mRNA cancer treatment has achieved the targets in the last stage trials of melanoma. Let us tell you that melanoma is a serious form of skin cancer. Dr. Ryan Sullivan, director of the Melanoma Center at Massachusetts General Brigham Cancer Institute, told Reuters that the success is a major achievement for the field.
(Note- Before making any kind of investment in the stock market, definitely take advice from your market experts.)
—- End —-
Source: www.aajtak.in
